News

Shares of sensor manufacturer Sensata Technology (NYSE:ST) jumped 9.3% in the morning session after the company reported strong fourth-quarter results, which beat analysts' revenue, EBITDA, and EPS expectations. Notably, margins expanded significantly, as operating Margin rose to 8.1%, up from -20.3% in the same quarter last year. Inventory levels also improved. On the other hand, its revenue and EPS guidance for the next quarter missed. Overall, the outlook made this a weaker quarter because ma

Shares of rail equipment company Westinghouse Air Brake Technologies (NYSE:WAB) fell 11.1% in the morning session after the company delivered a weaker-than-expected quarter, with both revenue and EPS missing estimates and guidance for both metrics coming in below Wall Street's expectations. Growth was weighed down by the Freight segment, where sales were nearly flat​. The Transit segment, however, grew 7.1%, helping lift overall revenue by 2.3%​. Wabtec also introduced a new five-year forecast,

Shares of online real estate marketplace Zillow (NASDAQ:ZG) fell 14.9% in the morning session after the company reported disappointing fourth-quarter quarterly results as it provided quarterly guidance for sales and EBITDA below Wall Street's expectations.

Shares of ride sharing service Lyft (NASDAQ: LYFT) fell 14.6% in the pre-market session after the company reported disappointing fourth-quarter results: Its revenue slightly missed, and its EBITDA guidance for the next quarter fell short of Wall Street's estimates. The outlook suggests some bumps in the road ahead, but this quarter still had its bright spots as Lyft blew past analysts' EBITDA and EPS expectations. Expectations had soared earlier in the week after the company signaled a possible

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported strong fourth-quarter results that exceeded expectations, with same-store sales significantly surpassing analysts' forecasts and EPS outperforming Wall Street's estimates by a wide margin. Growth was powered by strong performance in the Pharmacy & Consumer Wellness segment​. On the other hand, its full-year EPS guidance missed. Despite this, we think this was a decent qua

Shares of scientific instruments company Waters Corporation (NYSE:WAT) fell 9% in the morning session after the company reported disappointing fourth quarter results: Its revenue and EPS guidance for next quarter fell short of Wall Street's estimates. whole, was underwhelming. The company highlighted headwinds related to foreign exchange, volume, and inflation. Also, the sales outlook suggests growth will trudge along in the mid-single digits, given foreign exchange pressures.

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.6% in the morning session after the company reported impressive fourth-quarter results that exceeded analysts' revenue, EPS, and adjusted operating income estimates. Revenue grew 6%, driven by a 16% increase in HIV product sales and supported by strength in oncology and liver disease products. The momentum is expected to continue into the next year, as full-year EPS guidance surpassed Wall Street estimates, while sales gu